Abstract:To elucidate the roles of vitrification of stabilizers/matrix formers for the redispersibility of drug nanocrystal powder after solidification at storage stress, the influence of different drying methods and storage stresses on stability of drug nanocrystals was systemically investigated. A poorly soluble drug, baicalin, used as model drug was converted into baicalin nanocrystals (BCN-NC). The residual moisture contents of BCN-NC were applied at two different stress conditions defined as "conservative" (<1%) and "aggressive" (>1%), respectively. The influence of different stabilizers, matrix formers, and storage stresses on the redispersibility of BCN-NC powder was systemically investigated, respectively. The results showed that storage stresses had significantly influence the redispersibility of BCN-NC. Aggressive storage temperature and residual moisture could be unfavorable factors for stability of drug nanocrystals, due to the exacerbation of aggregation of BCN-NC induced by vitrification. It was demonstrated that vitrification of spray-dried BCN-NC was dependent on temperature and time. The polymeric stabilizers hydroxypropylmethylcellulose (HPMC) and sodium carboxymethyl starch (CMS-Na) with high glass transition temperature (T g) played more important role in protecting the BCN-NC from breakage during storage, compared to the surfactants Tween 80, D-α-tocopherol acid polyethylene glycol 1000 succinate (TPGS), or RH 40. Besides, the polyvinylpyrrolidone K30 (PVP K30) and lactose with high T g were effective matrix formers for preserving the redispersibility of BCN-NC. It was concluded that the vitrification transition of stabilizers/matrix formers could be responsible for aggregation of drug nanocrystals during storage, which was a time-dependent process. The suitable residual moisture contents (RMC) and T g were very important for preserving the stability of drug nanocrystals during storage.

Progress in the development of stabilization strategies for nanocrystal preparations

Stability of Nanosuspensions in Drug Delivery

The Roles of Vitrification of Stabilizers/Matrix Formers for the Redispersibility of Drug Nanocrystals After Solidification: a Case Study

Recent developments in the use of nanocrystals to improve bioavailability of APIs

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

A Nanocrystal Platform Based on Metal-Phenolic Network Wrapping for Drug Solubilization

Nanocrystal technology for drug formulation and delivery

Nanocrystal technology as a strategy to improve drug bioavailability and antitumor efficacy for the cancer treatment.

Advances of Combinative Nanocrystal Preparation Technology for Improving the Insoluble Drug Solubility and Bioavailability

Nanocrystals Technology for Pharmaceutical Science.

Crystallization Methods for Preparation of Nanocrystals for Drug Delivery System

State of the art of nanocrystals technology for delivery of poorly soluble drugs

Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals

Recent Trends in Nanocrystals for Pharmaceutical Applications.

Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system

Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques

Study on the Stabilization Mechanisms of Wet-Milled Cepharanthine Nanosuspensions Using Systematical Characterization.

A carbohydrate polymer is a critical variable in the formulation of drug nanocrystals: a case study of idebenone

Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications

A mini review of nanosuspensions development.

Strategies and methods of nanocrystal technology for targeting drug delivery